Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Only 12 Evaluable Patients at 450 days 67% CR !!!!!!

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Apr 26, 2023 8:08pm

166 Views

Post# 35415952

RE:RE:RE:Only 12 Evaluable Patients at 450 days 67% CR !!!!!!

I'm not sure yet, but I think they may have changed the definition of "evaluable" I think it now means the patients that could be evaluated at any point in time. So at 450 days all of the no response patients were dropped except the 2 that were actually evaluated no reponse at 450 days. I still need to dig a some more.

DJDawg wrote: That is so strange. I feel like the AUA poster will be needed to clean up the data presentation.
12 evaluable makes no sense when they said 29 evaluable before.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"